From r-help-bounces@stat.math.ethz.ch  Fri Jun 15 15:40:36 2007
Return-Path: <r-help-bounces@stat.math.ethz.ch>
Received: from hypatia.math.ethz.ch (hypatia.math.ethz.ch [129.132.145.15])
	by flax9.uwaterloo.ca (8.12.8/8.12.5) with ESMTP id l5FJeZL9006012
	for <ktwarwic@flax9.uwaterloo.ca>; Fri, 15 Jun 2007 15:40:35 -0400
Received: from hypatia.math.ethz.ch (hypatia [129.132.145.15])
	by hypatia.math.ethz.ch (8.13.6/8.13.6) with ESMTP id l5FJdrSA027475;
	Fri, 15 Jun 2007 21:40:07 +0200
X-Spam-Checker-Version: SpamAssassin 3.2.0 (2007-05-01) on hypatia.math.ethz.ch
X-Spam-Level: *
X-Spam-Status: No, score=1.2 required=5.0 tests=AWL, BAYES_95, DKIM_SIGNED,
	DKIM_VERIFIED autolearn=no version=3.2.0
Received: from py-out-1112.google.com (py-out-1112.google.com [64.233.166.180])
	by hypatia.math.ethz.ch (8.13.6/8.13.6) with ESMTP id l5FJUkJJ023472
	for <r-help@stat.math.ethz.ch>; Fri, 15 Jun 2007 21:30:48 +0200
Received: by py-out-1112.google.com with SMTP id f31so1732675pyh
	for <r-help@stat.math.ethz.ch>; Fri, 15 Jun 2007 12:30:46 -0700 (PDT)
Received: by 10.65.95.12 with SMTP id x12mr5821764qbl.1181935845985;
	Fri, 15 Jun 2007 12:30:45 -0700 (PDT)
Received: by 10.65.61.8 with HTTP; Fri, 15 Jun 2007 12:30:45 -0700 (PDT)
Message-ID: <40e66e0b0706151230o1e3a8f49va55f28f4e9cb689d@mail.gmail.com>
Date: Fri, 15 Jun 2007 14:30:45 -0500
From: "Spielas Bates" <bates@stat.wisc.edu>
To: "Nicholas Lewin-Koh" <nikko@hailmail.net>
In-Reply-To: <1181934193.4957.1195396717@webmail.messagingengine.com>
MIME-Version: 1.0
Content-Disposition: inline
References: <1181934193.4957.1195396717@webmail.messagingengine.com>
X-Google-Sender-Auth: 9663ba565fc664c8
X-Virus-Scanned: by amavisd-new at stat.math.ethz.ch
Cc: r-help@stat.math.ethz.ch
Subject: Re: [R] R vs. Splus in Pharma/Devices Industry
X-BeenThere: r-help@stat.math.ethz.ch
X-Mailman-Version: 2.1.9
Precedence: list
List-Id: "Main R Mailing List: Primary help" <r-help.stat.math.ethz.ch>
List-Unsubscribe: <https://stat.ethz.ch/mailman/listinfo/r-help>,
	<mailto:r-help-request@stat.math.ethz.ch?subject=unsubscribe>
List-Archive: <https://stat.ethz.ch/pipermail/r-help>
List-Post: <mailto:r-help@stat.math.ethz.ch>
List-Help: <mailto:r-help-request@stat.math.ethz.ch?subject=help>
List-Subscribe: <https://stat.ethz.ch/mailman/listinfo/r-help>,
	<mailto:r-help-request@stat.math.ethz.ch?subject=subscribe>
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7bit
Sender: r-help-bounces@stat.math.ethz.ch
Errors-To: r-help-bounces@stat.math.ethz.ch

On 6/15/07, Nicholas Lewin-Koh <nikko@hailmail.net> wrote:
> Hi,
> I just saw this thread. This issue, and the larger scale issue of open
> source in industry
> is being addressed. One has to realize that the behemoth that is the
> clinical aperatus
> of the pharma industry is very conservative and very slow to change. In
> many cases
> switching to R would meean changing a great many processes all based on
> legacy code. One
> of the big issues is that the industry demands consistency not
> necessarily correctness.
>
> All that said there are a great many areas where R could be used that
> would not impact
> regulatory submission, data security etc. Many in pharma are quietly
> working on this,
> but steps are small and incremental. Development takes time in industry
> because of the amount of
> documentation necessary. All this impacts the "free" nature of R and
> cost and risk (From the industries
> perspective) need to be justified.

> Probably when the statistical community is using Z big pharma will be
> ready to use
> R. %P

I think you mean A, not Z.  First there was S, then there was R.

______________________________________________
R-help@stat.math.ethz.ch mailing list
https://stat.ethz.ch/mailman/listinfo/r-help
PLEASE do read the posting guide http://www.R-project.org/posting-guide.html
and provide commented, minimal, self-contained, reproducible code.

